Luyan Pharma Co.,Ltd. (SHE:002788)
China flag China · Delayed Price · Currency is CNY
13.38
-0.45 (-3.25%)
Mar 26, 2026, 3:04 PM CST

Luyan Pharma Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
5,3733,1903,4933,2363,0343,081
Market Cap Growth
68.04%-8.68%7.92%6.66%-1.51%15.67%
Enterprise Value
9,9427,8608,2167,7217,0526,338
Last Close Price
13.837.888.317.456.746.68
PE Ratio
17.299.239.619.389.9211.56
PS Ratio
0.260.160.180.170.170.20
PB Ratio
1.651.001.171.161.191.26
P/TBV Ratio
2.071.271.521.441.491.55
P/FCF Ratio
15.9214.744.48---
P/OCF Ratio
8.825.522.6713.94-51.01
EV/Sales Ratio
0.480.380.410.400.400.41
EV/EBITDA Ratio
13.1710.4710.9010.1910.7710.59
EV/EBIT Ratio
16.0411.4911.8210.9911.7511.52
EV/FCF Ratio
29.4536.3310.54---
Debt / Equity Ratio
1.531.551.631.821.751.43
Debt / EBITDA Ratio
6.636.095.966.236.295.85
Debt / FCF Ratio
14.8222.886.23---
Net Debt / Equity Ratio
1.391.371.431.611.591.19
Net Debt / EBITDA Ratio
6.575.835.645.926.224.85
Net Debt / FCF Ratio
13.4620.225.45-47.03-6.61-26.31
Asset Turnover
1.641.681.681.791.891.93
Inventory Turnover
7.096.977.167.447.527.56
Quick Ratio
0.770.770.790.790.800.81
Current Ratio
1.101.151.161.171.191.22
Return on Equity (ROE)
9.69%11.27%12.64%13.12%12.17%12.31%
Return on Assets (ROA)
3.05%3.50%3.68%4.03%4.04%4.27%
Return on Invested Capital (ROIC)
6.06%7.10%7.44%7.61%7.35%7.80%
Return on Capital Employed (ROCE)
16.40%17.00%18.40%20.20%20.20%20.70%
Earnings Yield
5.73%10.84%10.41%10.66%10.08%8.65%
FCF Yield
6.28%6.78%22.33%-2.95%-20.29%-3.58%
Dividend Yield
2.60%4.44%3.61%4.03%4.45%2.99%
Payout Ratio
106.59%93.69%93.56%95.92%81.76%79.93%
Buyback Yield / Dilution
0.25%-0.42%0.28%-0.17%-7.46%-9.83%
Total Shareholder Return
2.85%4.02%3.89%3.86%-3.00%-6.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.